Lara Meisner
Chief Legal Officer · Bicara Therapeutics Inc.
- 2025
- Feb 4, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lara Meisner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Claire Mazumdar - $3.59M in BCAX purchases and sales in the last 12 months
- Ryan Cohlhepp - $3.46M in BCAX purchases and sales in the last 12 months
- Ivan Hyep - $2.40M in BCAX purchases and sales in the last 12 months
- David Raben - $741K in BCAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lara Meisner?
Lara Meisner is a corporate insider, tracked as Chief Legal Officer of Bicara Therapeutics Inc. (BCAX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lara Meisner last file a Form 4?
The most recent primary Form 4 on record is dated 4 February 2026, one of 3 filings going back to 2025.
Has Lara Meisner been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($681K) across all tracked filings.
